Literature DB >> 2874792

A role for transglutaminase in glucose-stimulated insulin release from the pancreatic beta-cell.

P J Bungay, R A Owen, I C Coutts, M Griffin.   

Abstract

Preincubation of rat islets of Langerhans with the potent inhibitors of islet transglutaminase activity, monodansylcadaverine (30-100 microM) and N-(5-aminopentyl)-2-naphthalenesulphonamide (100-200 microM), led to significant inhibition of glucose-stimulated insulin release from islets. In contrast, the respective N'-dimethylated derivatives of these two compounds, which did not inhibit islet transglutaminase activity, were much less effective as inhibitors of glucose-stimulated insulin release. None of the compounds inhibited rat spleen protein kinase C activity at concentrations which gave rise to inhibition of glucose-stimulated insulin release. When tested for their effects on calmodulin-stimulated bovine heart phosphodiesterase activity, of the compounds that inhibited insulin release, only monodansylcadaverine did not act as an effective antagonist of calmodulin at concentrations (up to 50 microM) that gave rise to significant inhibition of glucose-stimulated insulin release. Furthermore, at 50 microM, monodansylcadaverine did not inhibit methylation of islet lipids. The inhibition of glucose-stimulated insulin release by monodansylcadaverine is therefore likely to be attributable to its interference with islet transglutaminase activity. The sensitivity of islet transglutaminase to activation by Ca2+ was investigated by using a modified assay incorporating dephosphorylated NN'-dimethylcasein as a substrate protein. The Km for Ca2+ obtained (approx. 3 microM) was an order of magnitude lower than previously reported for the islet enzyme [Bungay, Potter & Griffin (1984) Biochem. J. 219, 819-827]. Mg2+ (2 mM) was found to have little effect on the sensitivity of the enzyme to Ca2+. Investigation of the endogenous substrate proteins of islet transglutaminase by using the Ca2+-dependent incorporation of [14C]methylamine into proteins of islet homogenates demonstrated that most of the incorporated radiolabel was present in cross-linked polymeric aggregates which did not traverse 3% (w/v) acrylamide gels. The radiolabelled polymeric aggregates were present in 71 000 g-sedimented material of homogenates, and their formation was transglutaminase-mediated. These findings provide new evidence for the involvement of islet transglutaminase in the membrane-mediated events necessary for glucose-stimulated insulin release.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874792      PMCID: PMC1146677          DOI: 10.1042/bj2350269

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

Review 1.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

2.  A role for polyamines in stimulus-secretion coupling in the pancreatic beta-cell.

Authors:  P J Bungay; J M Potter; M Griffin
Journal:  Biosci Rep       Date:  1984-10       Impact factor: 3.840

3.  Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein.

Authors:  D Hand; P J Bungay; B M Elliott; M Griffin
Journal:  Biosci Rep       Date:  1985-12       Impact factor: 3.840

4.  Glucose increases cytosolic Ca2+ activity in pancreatic islet cells.

Authors:  M Deleers; M Mahy; W J Malaisse
Journal:  Biochem Int       Date:  1985-01

5.  Identification and characterization of Ca2+-phospholipid-dependent protein kinase in rat islets and hamster beta-cells.

Authors:  J M Lord; S J Ashcroft
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

Review 6.  Cytosolic free Ca2+ in insulin secreting cells and its regulation by isolated organelles.

Authors:  M Prentki; C B Wollheim
Journal:  Experientia       Date:  1984-10-15

7.  Effects of extracellular calmodulin and calmodulin antagonists on B16 melanoma cell growth.

Authors:  S Mac Neil; S W Walker; H J Senior; S S Bleehen; S Tomlinson
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

8.  Impairment of insulin release by methylation inhibitors.

Authors:  L Best; P Lebrun; M Saceda; P Garcia-Morales; C Hubinont; M Juvent; A Herchuelz; F Malaisse-Lagae; I Valverde; W J Malaisse
Journal:  Biochem Pharmacol       Date:  1984-07-01       Impact factor: 5.858

9.  Methylamine and islet function: possible relationship to Ca2+-sensitive transglutaminase.

Authors:  A Sener; R Gomis; P Lebrun; A Herchuelz; F Malaisse-Lagae; W J Malaisse
Journal:  Mol Cell Endocrinol       Date:  1984-07       Impact factor: 4.102

10.  The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism.

Authors:  P J Bungay; J M Potter; M Griffin
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

View more
  16 in total

1.  Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2.

Authors:  U S Singh; M T Kunar; Y L Kao; K M Baker
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Changes in transglutaminase activity in carbon tetrachloride-damaged rat liver.

Authors:  H Kohno; K Kashimura; S Katoh; Y Ohkubo
Journal:  Experientia       Date:  1991-01-15

3.  Post-translational modification of apolipoprotein B by transglutaminases.

Authors:  E Cocuzzi; M Piacentini; S Beninati; S I Chung
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

4.  Purification and characterization of a cytosolic transglutaminase from a cultured human tumour-cell line.

Authors:  C Y Dadabay; L J Pike
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

5.  Differential expression of tissue transglutaminase in human cells. An immunohistochemical study.

Authors:  V Thomázy; L Fésüs
Journal:  Cell Tissue Res       Date:  1989-01       Impact factor: 5.249

6.  An Islet-Targeted Genome-Wide Association Scan Identifies Novel Genes Implicated in Cytokine-Mediated Islet Stress in Type 2 Diabetes.

Authors:  Poonam R Sharma; Aaron J Mackey; Eden A Dejene; James W Ramadan; Carl D Langefeld; Nicholette D Palmer; Kent D Taylor; Lynne E Wagenknecht; Richard M Watanabe; Stephen S Rich; Craig S Nunemaker
Journal:  Endocrinology       Date:  2015-05-27       Impact factor: 4.736

7.  Transglutaminase in azoxymethane-induced colon cancer in the rat.

Authors:  G D'Argenio; P Iovino; V Cosenza; I Sorrentini; F De Ritis; M Delle Cave; F P D'Armiento; G Mazzacca
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

8.  Detection of Ca2+-dependent transglutaminase activity in root and leaf tissue of monocotyledonous and dicotyledonous plants

Authors: 
Journal:  Plant Physiol       Date:  1998-07       Impact factor: 8.340

9.  Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides.

Authors:  P A Smethurst; M Griffin
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

10.  Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation.

Authors:  Nils Paulmann; Maik Grohmann; Jörg-Peter Voigt; Bettina Bert; Jakob Vowinckel; Michael Bader; Masa Skelin; Marko Jevsek; Heidrun Fink; Marjan Rupnik; Diego J Walther
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.